Terms: = Ovarian cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Prognosis
9 results:
1. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
2. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457
[No Abstract] [Full Text] [Related]
3. bcl7C suppresses ovarian cancer growth by inactivating mutant p53.
Huang C; Hao Q; Shi G; Zhou X; Zhang Y
J Mol Cell Biol; 2021 May; 13(2):141-150. PubMed ID: 33306126
[TBL] [Abstract] [Full Text] [Related]
4. Low bcl7a expression predicts poor prognosis in ovarian cancer.
Sun Z; Sun L; He M; Pang Y; Yang Z; Wang J
J Ovarian Res; 2019 May; 12(1):41. PubMed ID: 31077237
[TBL] [Abstract] [Full Text] [Related]
5. Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis.
Wei S; Liu J; Shi Y; Zhang X; Yang Y; Song Q
Mol Med Rep; 2017 Sep; 16(3):3155-3160. PubMed ID: 28713952
[TBL] [Abstract] [Full Text] [Related]
6. Risk of premature menopause after treatment for Hodgkin's lymphoma.
Swerdlow AJ; Cooke R; Bates A; Cunningham D; Falk SJ; Gilson D; Hancock BW; Harris SJ; Horwich A; Hoskin PJ; Linch DC; Lister A; Lucraft HH; Radford J; Stevens AM; Syndikus I; Williams MV;
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25139687
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.
Serce NB; Boesl A; Klaman I; von Serényi S; Noetzel E; Press MF; Dimmler A; Hartmann A; Sehouli J; Knuechel R; Beckmann MW; Fasching PA; Dahl E
BMC Cancer; 2012 Dec; 12():597. PubMed ID: 23236990
[TBL] [Abstract] [Full Text] [Related]
8. Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.
Chetrit A; Hirsh-Yechezkel G; Ben-David Y; Lubin F; Friedman E; Sadetzki S
J Clin Oncol; 2008 Jan; 26(1):20-5. PubMed ID: 18165636
[TBL] [Abstract] [Full Text] [Related]
9. Brain metastases from epithelial ovarian cancer.
Tay SK; Rajesh H
Int J Gynecol Cancer; 2005; 15(5):824-9. PubMed ID: 16174231
[TBL] [Abstract] [Full Text] [Related]
